XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenue:    
License and collaboration revenue $ 10,000  
Total revenue 10,000  
Operating expenses:    
Research and development 34,915 $ 22,645
General and administrative 12,415 4,933
Total operating expenses 47,330 27,578
Loss from operations (37,330) (27,578)
Other income (expense), net:    
Fair value adjustments to convertible notes   (694)
Other income, net 3,552 472
Total other income (expense), net 3,552 (222)
Loss before income taxes (33,778) (27,800)
Income tax benefit 205  
Net loss to common stockholders $ (33,573) $ (27,800)
Net loss per share attributable to common stockholders - basic (in dollars per share) $ (0.8) $ (17.89)
Net loss per share attributable to common stockholders - diluted (in dollars per share) $ (0.8) $ (17.89)
Weighted-average common stock outstanding - basic (in shares) 41,800,802 1,554,087
Weighted-average common stock outstanding - diluted (in shares) 41,800,802 1,554,087
Comprehensive loss:    
Net loss to common stockholders $ (33,573) $ (27,800)
Other comprehensive income (loss):    
Unrealized gain on investments 12  
Foreign currency translation adjustment (65) 37
Comprehensive loss $ (33,626) $ (27,763)